Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BISOPROLOL Cause Antimicrobial susceptibility test resistant? 25 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Antimicrobial susceptibility test resistant have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.1% of all adverse event reports for BISOPROLOL.

25
Reports of Antimicrobial susceptibility test resistant with BISOPROLOL
0.1%
of all BISOPROLOL reports
0
Deaths
25
Hospitalizations

How Dangerous Is Antimicrobial susceptibility test resistant From BISOPROLOL?

Of the 25 reports, 25 (100.0%) required hospitalization.

Is Antimicrobial susceptibility test resistant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does BISOPROLOL Cause?

Dyspnoea (2,940) Bradycardia (2,535) Hypotension (2,504) Dizziness (2,153) Fall (2,011) Fatigue (1,983) Acute kidney injury (1,894) Malaise (1,602) Drug ineffective (1,486) Nausea (1,460)

What Other Drugs Cause Antimicrobial susceptibility test resistant?

DAPTOMYCIN (97) VANCOMYCIN (44) DUTASTERIDE (30) ALFUZOSIN (29) LANSOPRAZOLE (29) TRAMADOL (27) CILASTATIN\IMIPENEM (15) CUBICIN (14) CIPROFLOXACIN (11) PIPERACILLIN\TAZOBACTAM (11)

Which BISOPROLOL Alternatives Have Lower Antimicrobial susceptibility test resistant Risk?

BISOPROLOL vs BISOPROLOL\BISOPROLOL BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE BISOPROLOL vs BIVALIRUDIN BISOPROLOL vs BLEOMYCIN BISOPROLOL vs BLINATUMOMAB

Related Pages

BISOPROLOL Full Profile All Antimicrobial susceptibility test resistant Reports All Drugs Causing Antimicrobial susceptibility test resistant BISOPROLOL Demographics